Found: 20
Select item for more details and to access through your institution.
15th Annual University of Pennsylvania conference on statistical issues in clinical trial/advances in time to event analyses in clinical trials (morning panel discussion).
- Published in:
- Clinical Trials, 2024, v. 21, n. 5, p. 562, doi. 10.1177/17407745241272012
- By:
- Publication type:
- Article
Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 1, p. 8, doi. 10.1016/j.clbc.2014.07.007
- By:
- Publication type:
- Article
Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship between Treatment Effects on Progression-Free Survival and Overall Survival in Multiple Myeloma: A Systematic Review and Meta-Analysis of Published Clinical Trial Data.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 3, p. 88, doi. 10.1159/000375392
- By:
- Publication type:
- Article
Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 142, n. 2, p. 381, doi. 10.1007/s10549-013-2742-4
- By:
- Publication type:
- Article
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 2, p. 409, doi. 10.1007/s10549-010-0901-4
- By:
- Publication type:
- Article
A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 1, p. 36, doi. 10.1002/cam4.333
- By:
- Publication type:
- Article
Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.672916
- By:
- Publication type:
- Article
Optimal PD-L1–high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231936
- By:
- Publication type:
- Article
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 11, p. 2661, doi. 10.1007/s00520-012-1384-0
- By:
- Publication type:
- Article
Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 6, p. 1274, doi. 10.1002/cpt.1956
- By:
- Publication type:
- Article
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 4, p. 631, doi. 10.1002/cpt.982
- By:
- Publication type:
- Article
Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 4, p. 643, doi. 10.1002/cpt.986
- By:
- Publication type:
- Article
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 4, p. 583, doi. 10.1007/s00280-012-1943-6
- By:
- Publication type:
- Article
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 461, doi. 10.1002/cncr.26213
- By:
- Publication type:
- Article
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII-Tubulin Expression as a Predictive Marker.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 787, doi. 10.1634/theoncologist.2013-0075
- By:
- Publication type:
- Article
Validation of Companion Diagnostic for Detection of Mutations in Codons 12 and 13 of the KRAS Gene in Patients with Metastatic Colorectal Cancer.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 6, p. 820, doi. 10.5858/arpa.2012-0367-OA
- By:
- Publication type:
- Article
Addressing the Impact of the COVID-19 Pandemic on Survival Outcomes in Randomized Phase III Oncology Trials.
- Published in:
- Journal of Data Science, 2023, v. 21, n. 4, p. 781, doi. 10.6339/22-JDS1079
- By:
- Publication type:
- Article